These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18477557)

  • 1. Rosiglitazone-induced anasarca without heart failure: capillary leakage?
    Dagdelen S; Kurt M; Aydin K; Bayraktar M
    Hormones (Athens); 2008; 7(2):180-3. PubMed ID: 18477557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage.
    Rennings AJ; Smits P; Stewart MW; Tack CJ
    Diabetologia; 2010 Sep; 53(9):1856-66. PubMed ID: 20499046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Kermani A; Garg A
    Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pulmonary edema due to rosiglitazone use in a patient with diabetes mellitus.
    Cekmen N; Cesur M; Cetinbas R; Bedel P; Erdemli O
    J Intensive Care Med; 2006; 21(1):47-50. PubMed ID: 16698744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Jamieson A; Abousleiman Y
    Mayo Clin Proc; 2004 Apr; 79(4):571; author reply 575-7. PubMed ID: 15065625
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Mikhail NE; Wali S; Cope D
    Mayo Clin Proc; 2004 Apr; 79(4):571-2; author reply 575-7. PubMed ID: 15065626
    [No Abstract]   [Full Text] [Related]  

  • 7. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.
    Mudaliar S; Chang AR; Henry RR
    Endocr Pract; 2003; 9(5):406-16. PubMed ID: 14583425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinedione-induced edema in patients with heart failure.
    Stroup JS
    Am J Health Syst Pharm; 2007 Dec; 64(23):2426-30; author reply 2430. PubMed ID: 18029947
    [No Abstract]   [Full Text] [Related]  

  • 9. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Bell DS
    Mayo Clin Proc; 2004 Apr; 79(4):572; author reply 575-7. PubMed ID: 15065627
    [No Abstract]   [Full Text] [Related]  

  • 10. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
    Bowlin SJ; Koro CE
    Mayo Clin Proc; 2004 Apr; 79(4):572, 575; author reply 575-7. PubMed ID: 15065628
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
    Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
    Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms.
    Wang F; Vergara C; Carabino J; Desilets A; Vasquez R
    Am J Health Syst Pharm; 2004 Aug; 61(15):1604-8. PubMed ID: 15372837
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin.
    Marceille JR; Goins JA; Soni R; Biery JC; Lee TA
    Pharmacotherapy; 2004 Oct; 24(10):1317-22. PubMed ID: 15628829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.
    Page RL; Gozansky WS; Ruscin JM
    Pharmacotherapy; 2003 Jul; 23(7):945-54. PubMed ID: 12885108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone and heart failure: long-term vigilance.
    Singh N
    J Cardiovasc Pharmacol Ther; 2004 Mar; 9(1):21-5. PubMed ID: 15094965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinedione-induced congestive heart failure.
    Cheng AY; Fantus IG
    Ann Pharmacother; 2004 May; 38(5):817-20. PubMed ID: 15039476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do thiazolidinediones cause congestive heart failure?
    Kennedy FP
    Mayo Clin Proc; 2003 Sep; 78(9):1076-7. PubMed ID: 12962160
    [No Abstract]   [Full Text] [Related]  

  • 19. Unilateral edema due to a thiazolidinedione.
    Bell DS
    Diabetes Care; 2003 Sep; 26(9):2700. PubMed ID: 12941750
    [No Abstract]   [Full Text] [Related]  

  • 20. Do thiazolidinediones cause heart failure? A critical review.
    Tang WH
    Cleve Clin J Med; 2006 Apr; 73(4):390-7. PubMed ID: 16610400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.